CRNX — Crinetics Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-07-18.
Performance
Technicals
Others in Healthcare
Measured signals that fired on CRNX
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-08-05 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-08-04 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-08 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-07-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-06 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-07 | Struthers Richard Scott President & CEO | Option exercise | 6.5K | 15.29 | 100.0K |
| 2026-08-07 | Struthers Richard Scott President & CEO | Option exercise | 5.0K | 20.02 | 100.0K |
| 2026-08-07 | Struthers Richard Scott President & CEO | Option exercise | 4.4K | 22.61 | 100.0K |
| 2026-08-07 | Struthers Richard Scott President & CEO | Option exercise | 4.0K | 25.19 | 100.0K |
| 2026-07-02 | Vivaldi Coelho Rogerio Director | Open-market sale 10b5-1 plan | 3.0K | 40.00 | 120.0K |
| 2026-06-18 | Okey Stephanie Director | Grant or award | 5.9K | 0.00 | 0 |
| 2026-06-18 | Nichols Weston Director | Grant or award | 5.9K | 0.00 | 0 |
| 2026-06-18 | Vivaldi Coelho Rogerio Director | Grant or award | 5.9K | 0.00 | 0 |
| 2026-06-18 | WIERENGA WENDELL Director | Grant or award | 5.9K | 0.00 | 0 |
| 2026-06-18 | Bedrosian Camille L Director | Grant or award | 5.9K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| FMR LLC | 572.4M | 15.8M |
| BlackRock, Inc. | 308.0M | 8.5M |
| FARALLON CAPITAL MANAGEMENT LLC | 302.8M | 8.3M |
| WELLINGTON MANAGEMENT GROUP LLP | 296.3M | 8.2M |
| Driehaus Capital Management LLC | 232.3M | 6.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 169.8M | 4.7M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 168.5M | 4.6M |
| JANUS HENDERSON GROUP PLC | 164.2M | 4.5M |
| EcoR1 Capital, LLC | 155.7M | 4.3M |
| Bellevue Group AG | 119.1M | 3.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Crinetics Pharmaceuticals, Inc. (CRNX) filed form 8-K · 2026-08-19 · SEC EDGAR
- Crinetics Pharmaceuticals, Inc. (CRNX) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about CRNX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →